CYDY Company Profile

CYDY Time & Sales

CYDY Recent News

CYDY Filings

CYDY Financials

CYDY Buy Rating

Evil Rabbit

07/23/2025 10:03:41 AM

That premarket action was some BS. 11k (6)

dfwl28

07/23/2025 9:55:10 AM

Side effects of Ipilimumab, also known (4)

ohm20

07/23/2025 4:01:10 AM

Ipilimumab Safety Profile: Associated (16)

ohm20

07/23/2025 3:50:15 AM

Based on above hypothesis, It could (11)

KenChowder

07/23/2025 3:13:18 AM

MGK wrote: Based on above hypothesis, (11)

ohm20

07/23/2025 2:56:21 AM

Sorry Ohm, I'm not smart enough to (13)

USS JOHNSTON

07/22/2025 11:27:56 PM

I am also not a doctor, biloxi, so I (5)

MGK_2

07/22/2025 8:09:36 PM

I wrote (4)

biloxiblues

07/22/2025 7:37:02 PM

I am not a Doctor, but this is (4)

craigakess

07/22/2025 7:24:09 PM

Thanks for posting the response. (5)

Mr3Putt

07/22/2025 7:05:07 PM

UWS responds to you at r/Livimmune: (3)

SeeWhyDY

07/22/2025 5:49:35 PM

Am I reading this article (2)

skezan

07/22/2025 4:42:55 PM

Sorry Ohm, I'm not smart enough to (2)

ohm20

07/22/2025 3:34:27 PM

Ipilimumab is an antibody that binds to (10)

craigakess

07/22/2025 1:50:53 PM

Thanks for posting that as it is quite (6)

craigakess

07/22/2025 1:36:36 PM

Strange that it says the study was (2)

sean007

07/22/2025 1:34:19 PM

Europe Not entire (1)

Boatbuilder

07/22/2025 1:15:30 PM

Unfortunately not CYDY. (2)

docj

07/22/2025 12:28:38 PM

Good to see your post. It has been a

KenChowder

07/22/2025 11:16:35 AM

Another poster corrected me on the time (4)

Mr3Putt

07/22/2025 10:44:56 AM

The Jun 24 PR stated that the company (8)

sunray3

07/22/2025 10:36:07 AM

Well, I must admit that's a compelling (11)

Jake2212

07/22/2025 9:25:56 AM

sunray: Sounds good, but keep in mind. (10)

hoops

07/22/2025 9:23:24 AM

There is hope. (3)

KenChowder

07/22/2025 9:15:17 AM

Yes, that Reddit post is worth a read. (12)

sunray3

07/22/2025 9:05:38 AM

Agree, and as you say the acquirer must (11)

sherlock57

07/22/2025 4:42:15 AM

Thanks, 3Putt, for posting that. It's (22)

Mr3Putt

07/21/2025 10:31:35 PM

Require reading for the frustrated (14)

Ramjet

07/21/2025 8:24:56 PM

Agreed, months and years. I feel for (11)

sean007

07/21/2025 7:36:01 PM

"There is no crying in (2)

ohm20

07/21/2025 5:38:01 PM

Unfortunately, the ESMO presentations (20)

biloxiblues

07/21/2025 3:10:55 PM

This is an interesting read on Cytodyn (4)

Tprovo

07/21/2025 2:38:41 PM

I was expecting we would get a shove (2)

Niele

07/21/2025 2:36:18 PM

When we start bickering ourselves and (18)

sherlock57

07/21/2025 2:24:34 PM

In 2024 Cytodyn published 18 press (25)

Katangolo

07/21/2025 2:08:05 PM

Of all days, Ive never been more (17)

hoops

07/21/2025 12:40:21 PM

Check the bid/ask spread.

hoops

07/21/2025 12:32:18 PM

Theres been unusual volatility over (1)

KenChowder

07/21/2025 12:10:16 PM

It might not be a bash, but it is no (5)

MidnightRider

07/21/2025 11:28:48 AM

There have to be good reasons for the (5)

hoops

07/21/2025 11:20:39 AM

Either they have nothing to report (11)

Mr3Putt

07/21/2025 7:01:29 AM

This info got posted at (7)

Cycl2R

07/20/2025 2:16:01 PM

brenty wrote They did share this... (6)

misiu143

07/20/2025 10:49:49 AM

How sad is that , how many months ago (14)

brentie

07/19/2025 9:28:41 PM

"Alzheimer Phase One? Is this another (7)

pnwtri

07/19/2025 5:55:17 PM

Cytodyn dropped GVHD pursuit a couple (2)

biloxiblues

07/19/2025 5:25:33 PM

Does leronlimab have orphan drug (11)

Cycl2R

07/19/2025 4:56:18 PM

Alzheimer Phase One? Is this another

Jake2212

07/19/2025 12:56:34 PM

Kat: Thanks for the incredible effort (11)

Katangolo

07/19/2025 12:56:07 PM

Yeah, Ive been untangling rats nests (4)

Newer

Older

Recent Articles

• Exploring the Strong Performance of Ares Management Stock
• Humanoid Global's New Marketing Initiatives Boost Growth Potential
• Exciting Developments at Quantum BioPharma Ltd. Unveiled
• Datavault AI Responds to Malicious Short Report with Confidence
• Incredible Growth of Uber Technologies Over Five Years
• How Your $100 Investment in Lam Research Is Now Worth Much More
• South Star Battery Metals Completes Successful Funding Tranche
• Sina Corporation Securities Case: Seek Counsel for Your Rights
• South Star Battery Metals Secures Funding for Growth ahead
• Transforming Investments: Hilton’s Growth Over a Decade
• Transforming $100 into a Fortune: Super Micro Computer's Journey
• Celebrating Healing Through Art: An Exhibit for Warriors
• Exciting Marketing Initiatives Announced by Refined Energy Corp.
• Lithium Ionic Releases Technical Report for Bandeira Project Update
• Understanding Iron Mountain's Stock Growth Over Time
• Metsera's Response to Legal Challenges and Future Prospects
• Investigating Tandem Diabetes Care, Inc. for Misleading Claims
• Datavault AI Responds Strongly to Baseless Short Report Allegations
• Monolithic Power Systems: Surge in Stock Price Explained
• Amazing Growth Potential: Krystal Biotech's Investment Success
• Grupo Aeroportuario del Pacifico's Operations Update After Hurricane
• Incredible Growth: The Journey of Netflix Investments
• Understanding the P/E Ratio for CommScope Holdings
• Transforming Rental Housing: Canadian Commitment to Affordability
• Important Update on Data Security from Langdon & Emison LLC
• Join the Battle: Investors Unite Against Molina Healthcare Fraud
• PRFoods Reports Successful Transition with Improved Financials
• Discover the Growth of $1000 in Green Brick Partners Today
• Crown Racing Competes in Radical World Finals at VIR
• Imperial Metals Efficiently Settles Unsecured Debentures
• Dynamix Corporation III's Successful IPO: A Fresh Beginning
• Knight Therapeutics Secures $100 Million Credit Facility
• Consolidated Lithium Metals Strengthens Financing Strategy
• Aventis Energy Completes Significant Financing for Growth
• Gran Tierra Energy's Strategic Confirmation on i3 Energy Acquisition
• KBR Investors: Key Actions Ahead of Securities Class Action Deadline
• Understanding Ten Years of Investment Growth in Stryker Corp
• Investors Urged to Act: Important Class Action Info for JSPR
• SohoMD Seeks Investment to Enhance Mental Health Services
• Gran Tierra Energy Updates Investors on i3 Acquisition Status
• Caliber Announces Innovative Debt-to-Equity Conversion Efforts
• Summit Hotel Properties Announces Strong Dividend Payments
• AeroVironment Investment Growth: A Decade of Success
• MoonLake Immunotherapeutics Class Action Details and Impacts
• Springview Holdings Ltd's Appeal Against Nasdaq Delisting Notice
• Serena Neel Unveils Exciting Holiday Bathroom Series on TikTok
• A Deep Dive Into Royal Caribbean Group's Long-Term Stock Growth
• Knight Therapeutics Secures $100M Credit Facility for Growth
• Understanding Nutanix's Stock Valuation Through P/E Ratio
• Aventis Energy Closes Flow-Through Financing for Growth!